Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04733495 · ClinicalTrials.gov registry record · NA
Group-Mediated Cognitive Behavioral Resistance Exercise Intervention in Head and Neck Cancer Patients Undergoing Chemoradiation Treatment
A NA study of Locally Advanced Head and Neck Squamous Cell Carcinoma, sponsored by Ohio State University Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT04733495: Completed NA study of Locally Advanced Head and Neck Squamous Cell Carcinoma, sponsored by Ohio State University Comprehensive Cancer Center.
NCT04733495 is a NA study of Locally Advanced Head and Neck Squamous Cell Carcinoma that has completed, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 20 participants, below the 344-participant average among 5 other Locally Advanced Head and Neck Squamous Cell Carcinoma trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04733495, a NA study of Locally Advanced Head and Neck Squamous Cell Carcinoma, has completed, sponsored by Ohio State University Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
This clinical trial examines a group-mediated cognitive behavioral resistance exercise intervention in head and neck cancer patients who are undergoing chemoradiation treatment. Chemoradiation is the established standard of care for locally advanced head and neck cancer patients. However, many head and neck cancer patients experience clinically meaningful declines in muscle mass, physical function, and quality of life during and following treatment. Resistance exercise has been shown to improve muscle mass, body composition, and physical function when integrated with appropriate standard of care nutritional counseling/supplementation. This trial may help researchers determine the important of integrating exercise interventions with routine cancer care.
Primary Outcome
Number of patients agreed to participate by signing the informed consent
Conditions Studied
Interventions
- OTHER Quality-of-Life Assessment
- OTHER Questionnaire Administration
- OTHER Counseling
- OTHER Resistance Training
- BEHAVIORAL Dietary Counseling and Surveillance
Study Locations (1)
Ohio
- Ohio State University Comprehensive Cancer Center - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2021-04-19 |
| Est. Completion | 2023-02-20 |
| Phase | NA |
What the finished NCT04733495 record still lists
NCT04733495 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 344-participant average among 5 other Locally Advanced Head and Neck Squamous Cell Carcinoma trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Locally Advanced Head and Neck Squamous Cell Carcinoma appearing as the primary indexed condition, and to 5 interventions - of which Quality-of-Life Assessment is the first listed.
NCT04733495 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT04733495 about?
NCT04733495 is a clinical study titled "Group-Mediated Cognitive Behavioral Resistance Exercise Intervention in Head and Neck Cancer Patients Undergoing Chemoradiation Treatment". This clinical trial examines a group-mediated cognitive behavioral resistance exercise intervention in head and neck cancer patients who are undergoing chemoradiation treatment. Chemoradiation is the established standard of care for locally advanced head and neck cancer patients. However, many head ...
What is the current status of trial NCT04733495?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2021-04-19. Estimated completion is 2023-02-20.
What conditions does trial NCT04733495 study?
This clinical trial studies the following conditions: Locally Advanced Head and Neck Squamous Cell Carcinoma.
What interventions are being tested in trial NCT04733495?
The interventions under investigation include: Quality-of-Life Assessment (OTHER), Questionnaire Administration (OTHER), Counseling (OTHER), Resistance Training (OTHER), Dietary Counseling and Surveillance (BEHAVIORAL).
Who is sponsoring clinical trial NCT04733495?
This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04733495 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Locally Advanced Head and Neck Squamous Cell Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer
RECRUITING · Phase 1
-
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
RECRUITING · Phase 3
-
JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC
RECRUITING · Phase 3
-
Tolinapant and Radiation for Cisplatin-Ineligible, Previously Untreated, Locally Advanced Head and Neck Cancer
ACTIVE NOT RECRUITING · Early Phase 1
-
Quad Shot Radiotherapy in Combination With Immune Checkpoint Inhibition
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI